Although we don’t yet have the FDA approval for these treatments, many patients are reporting improvement in damaged joints. Basically, everything is aging and as it does, it undergoes “osis”. “Itis” is inflamation but “osis” is being tired and burned out, largely because of worn out stem cells in those niches. Older joints are more prone to injury and their poor vascularization and worn out bone makes it harder to repair so surgeons often resect or replace.

The premise is that since your normal body healing is conducted by mesenchymal stem cells and their exosomes, that using exosomes from a newborn placenta’s stem cells will encourage regrowth using some form of replication, dedifferentiation, new vasculature, or reduction in inflammation.

Here is a testimonial from a 52yo patient whom I treated for a shoulder labral tear. If you do some research, you will learn that these can indeed heal on their own but that often, surgical resection, fixation, and reduced function after surgery are also common outcomes.

————————

Maria Jose Navarro, Nassau, The Bahamas

————————– 

I realize this is hard to understand but there are many proteins and mRNA in the exosomes that could be promoting new growth. Of course, this hasn’t been subjected to rigorous peer review or FDA approval. That said, if you recover function like my friend, 53yo Claude, who was able to ski 36 days this season after having severe pain and swelling in past years, it is risk that was associated with clear benefits. 

If you don’t believe that new cartilage can regrow then take a look at these knee films from my patient, a 73yo avid skier of large height and weight. He was (and still is) considering knee replacement so I hope that his recent second treatment of 7.5B each knee will regrow even more cartilage for him.